Healthcare -
Biotechnology - NASDAQ - US
$ 8.75
1.74 %
$ 602 M
Market Cap
-3.16
P/E
ARVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ARVN - Arvinas, Inc.
7.9 M
LAST VALUE
29.65%
2 YEAR CAGR
-43.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR